Preventing and managing chronic conditions

Developing and implementing lifestyle-based solutions to prevent and manage chronic conditions.

Research focus

We develop, implement, evaluate and translate lifestyle-based solutions to prevent and manage chronic conditions.

Researchers in this domain have expertise in:

  • The use of effective behaviour-change approaches for promoting physical activity and nutrition across the lifespan for chronic disease prevention and management
  • Conducting high-quality clinical and translational randomised controlled trials
  • Large-scale epidemiological studies
  • Digital health solutions
  • The assessment of cardiovascular, musculoskeletal and brain health and cognition using state-of-the-art techniques.

Research projects

Exercise interventions to minimise bone and muscle loss in obese older adults

Associate Professor David Scott is exploring exercise interventions to improve the health of older adults, of whom up to 40 per cent are obese and suffering significant disability and poor health.

Read more

Using a personalized Telehealth model to reduce falls and fracture risk in older adults

IPAN researchers are conducting a world-first trial on the role of telehealth as a new model of personalized healthcare delivery to prevent falls and fractures in older adults.

Read more

Using smart phones to improve cardiovascular health

Cardiovascular diseases are the leading causes of death, globally and in Australia. Now, an IPAN researcher is exploring how digital health can change management and prevention of cardiovascular disease.

Read more

Remotely supervised exercise training for heart failure

Exercise rehabilitation is vital for people with heart failure to improve their quality of life, avoid hospital admissions, and lower their risk of preventable death.

Read more

Using cardiac tele-rehabilitation to address inequalities in Western Victoria

This project aims to successfully implement a proven exercise telerehabilitation program for people with coronary heart disease (e.g. heart attack) into routine clinical practice.

Read more

Predictors of muscle loss in cancer treatment patients

Muscle loss is a serious issue for people undergoing treatment for lung cancer, potentially affecting their survival rates and quality of life.  Dr Nicole Kiss’ observational study is looking at predictors of muscle loss in people being treated for lung cancer to identify those most at risk.

Read more

Research groups

  • Digital health for lifestyle and disease management

    Group members: Associate Professor David Scott, Dr Shariful Islam, Dr Paul Jansons, Dr Kate Parker, Dr Jonathan Rawstorn, Dr Riaz Uddin, Dr Kim Way

    This group focuses on the development and evaluation of effective, scalable solutions for the prevention and management of chronic diseases, including (but not limited to) cardiovascular disease, diabetes and obesity. Our group has expertise in the development and evaluation of theory and evidence-based technology interventions across a range of settings (homes, hospitals and communities) and populations (adults and clinical populations).

    Our research incorporates the use of mobile devices, wearable sensors, home-sensing, and wearable cameras to measure and influence behavioural and health outcomes. We also have considerable expertise in the design and delivery of pragmatic, randomised controlled trials.

    This group covers:

    • Designing and evaluating the effectiveness of digital health interventions for the secondary prevention of disease
    • Understanding how technologies can be used to improve the reach, flexibility, and individualisation of interventions to modify behavioural risk factors for disease
    • Exploring the potential of wireless sensors and devices for monitoring physiological parameters and health-related behaviours
    • Investigating how to implement and deliver digital health solutions at scale.
  • Behavioural approaches to promote healthy lifestyles

    Group members: Dr Elena George, Dr Rebecca Lindberg, Dr Katherine Livingstone, Dr Helen Macpherson, Dr Megan Teychenne, Dr Kim Way

    This group focuses on the development and evaluation of effective behaviour change approaches for promoting both healthy eating and physically-active lifestyles.  Our group has expertise in the design, conduct and evaluation of theoretically-grounded, evidence-based behaviour change interventions targeting adults across a range of settings and populations, in both the general and clinical populations. Our group has a particular focus on addressing inequity and promoting healthy lifestyles among vulnerable groups, including those who are socioeconomically disadvantaged, with poor mental health, or with other chronic diseases.

    This group covers:

    • Investigating behavioural mediators of socioeconomic inequities in diet, physical activity and sedentary behaviours among adults
    • Developing behavioural interventions for healthy eating and physically-active lifestyles
    • Evaluating behavioural approaches to promoting healthy eating and physical activity amongst socioeconomically disadvantaged men and women
    • Evaluating behavioural approaches to promoting healthy eating and physical activity amongst people with/at risk of depression
    • Testing feasibility of established and novel approaches to promoting healthy eating and physical activity among vulnerable groups.
  • Musculoskeletal health and mobility

    Group leader:Professor Robin Daly

    Group members: Professor Judi Porter, Associate Professor Steve Fraser, Associate Professor Nicole Kiss, Associate Professor David Scott, Dr Brenton Baguley, Dr Jackson Fyfe, Dr Lee Hamilton, Dr Paul Jansons, Dr Patrick Owen, Dr Stuart Warmington

    This group focuses on the integration of exercise and nutritional approaches for the primary and secondary prevention of musculoskeletal-related conditions throughout the life course. Our group has specific expertise in conducting large-scale human clinical intervention trials and translational studies, particularly in the areas of osteoporosis, sarcopenia, falls and fractures and spinal health. There is also a strong focus on the prevention and management of musculoskeletal-related complications associated with other chronic diseases, including type 2 diabetes, kidney disease, certain types of cancer and cognitive related disorders.

    In terms of translational activities, our group has experience and expertise in conducting ‘research to practice’ trials, and evaluating their effectiveness within the community. Our group actively engages with relevant stakeholders – including medical practitioners, specialists, allied health professionals and industry – to inform policy, practice and clinical guidelines.

    This group covers:

    • Understanding the independent and combined effects of exercise and nutrition on musculoskeletal health and mobility across the lifespan
    • Exploring the mechanisms of musculoskeletal disease causation to guide the development of more effective and/or novel interventions
    • Designing and evaluating human clinical intervention trials to understand primary and secondary prevention of musculoskeletal related conditions, that will provide high-level evidence to inform policy, practice and clinical guidelines
    • Exploring the role of health technologies to aid the prescription of evidence-based exercise programs for healthy older adults and those with musculoskeletal-related conditions
    • Developing novel methodologies for assessing various musculoskeletal-related tissues (bone, body composition, cartilage, (inter)vertebral disc, marrow adipose tissue).
  • Exercise and nutrition for brain health

    Group leader:Dr Helen Macpherson

    Group members: Professor Robin Daly, Associate Professor Susan Torres, Dr Ash Hendy, Dr Catherine Milte, Dr Ewa Szymlek-Gay, Dr Megan Teychenne

    This group focuses on developing optimal nutrition, physical activity and exercise strategies to maximise brain health and cognitive function across the lifespan. In particular, our group is comprised of multi-disciplinary researchers with expertise ranging from molecular biology, analytical chemistry, proteomics, neurophysiology, cognitive neuroscience, neuroimaging, qualitative research methods, physical activity, sedentary behaviour and nutritional epidemiology and population-data analyses. Collectively, our research strengths are in the areas of ageing neuroscience, mental health, neuro-rehabilitation, and the conduct of clinical and translational intervention trials and large-scale epidemiological studies.

    This group covers:

    • Using state-of-the-art brain imaging and behavioral techniques for assessing cognition and brain function
    • Understanding the role of nutrition (including micronutrients, dietary patterns and supplements), physical activity and sedentary behaviour on healthy cognitive ageing, neurodegenerative diseases and mental illness across the lifespan
    • Conducting clinical intervention trials to evaluate the effectiveness of nutritional and exercise interventions, and their combination, on cognitive and mental health
    • Exploring the role of health technologies to deliver exercise programs to improve cognitive health and function in older adults and those with chronic neurodegenerative diseases (e.g. Parkinson’s disease and dementia)
    • Understanding and exploring the links between brain and cognitive health with other chronic conditions, such as sarcopenia, diabetes, stroke and lower back pain.
  • Exercise and nutrition for cancer

    Group members: Professor Robin Daly, Professor Judi Porter, Dr Brenton Baguley

    This group focuses on exercise and nutrition interventions to optimise musculoskeletal, nutritional, functional and quality of life outcomes for people with cancer. Members of our group have specific expertise in the evaluation of novel models of health care delivery, randomised controlled trials, and exercise and nutrition interventions, particularly in the area of lung, prostate, breast and adolescent and young adult cancers.

    Areas of focus include body composition changes and the impact of sarcopenia and bone loss on patient outcomes, recognition and management of cancer malnutrition, and optimised exercise and nutrition interventions that minimise adverse effects of cancer treatment. Our group has a strong national and international network of collaborators and partnerships in clinical health services and academic settings. Members have expertise in translation of research into direct improvements in clinical practice through contribution to national evidence-based clinical guidelines and resources for cancer clinicians.

    This group covers:

    • Understanding the effects of cancer treatment on patients’ musculoskeletal, cardiopulmonary, nutritional, functional and psychosocial outcomes
    • Optimising nutritional and exercise interventions that minimise the adverse effects of cancer treatment
    • Informing nutrition and exercise guidelines for cancer care
    • Educating cancer clinicians on the importance of exercise and nutritional interventions as part of usual care for cancer patients
    • Implementing novel models of health care delivery in the oncology setting.